Daily Stock List
With, Inc. (WWTH)
TopPennyStockMovers reported earlier on With, Inc. (WWTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, With, Inc. is the developer of the market-leading Hang w/ (Hang with) live streaming social media platform. Hang w/ connects people via live-streaming video and simultaneous chat. It allows anyone with an iPhone, iPad or Android device to broadcast live to viewers worldwide. The Company was previously known as MEDL Mobile Holdings, Inc. It changed its name to With, Inc. on October 26, 2015. A development company, With has its headquarters in Irvine, California.
Since its launch, the Hang w/ platform has reached millions of users across the app and by way of Facebook, Twitter and on the web. The platform has attracted hundreds of actors, athletes, musicians, as well as brands.
Hang w/ allows users to produce revenue through sharing revenue on pre- and post-roll integrated advertising; by enabling users to create mobile Pay-Per-View "Digital Ticket" events; and through user-to-user "Tipping" with digital coins that can be redeemed for cash.
With has tapped Mr. Kevin Harrington to help lead the Company into the multi-billion-dollar market of direct-to-consumer product sales. Mr. Harrington has launched in excess of 500 products. These have produced greater than $5 billion in global sales. He is widely known as the Inventor of the Infomercial and one of the founders of As Seen On TV.
In November 2015, With announced that it released a robust new update for the Hang w/ platform for Android. The update features a considerable improvement of the Android video broadcasting capabilities. It allows users to enjoy improved connection stability and also certain broadcast features, which were previously unavailable for Android.
This includes the ability to flip between the front-facing and rear-facing camera mid broadcast. In addition, the update contains a number of artistic and stylized live broadcast filters. This allows Android users to modify the look of their broadcasts on the go.
With, Inc. (WWTH), closed Friday's trading session at $0.0106, down 17.83%, on 61,200 volume with 8 trades. The average volume for the last 60 days is 393,642 and the stock's 52-week low/high is $0.006/$0.18.
VNUE, Inc. (VNUE)
Penny Dreamers, Jet-Life Penny Stocks, PennyStockLocks.com, ResearchOTC, StockRockandRoll, and Fortune Stock Alerts reported this week on VNUE, Inc. (VNUE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
VNUE, Inc. is a live entertainment music service company headquartered in New York, New York. The Company brings bands and fans together through capturing professional quality audio and video recordings of live performances. It delivers the experience of a venue to one’s home and hand. In essence, VNUE helps venue, artist, and industry unite as one. The Company lists on the OTC Markets Group’s OTCQB.
VNUE manages and simplifies the complexities of the music environment by streamlining the processes of curation, clearing, capturing, distribution and monetization. The Company captures content by way of its Front of House mobile application. VNUE provides global distribution and monetization via a complement of mobile, web administration applications. This enables an artist to seamlessly deliver and sell their live performances directly to the fans who attend their particular shows.
Regarding artists, VNUE gives them the tools to protect their live content and turn any performance into a record. Pertaining to fans, they can relive their favorite live performances over and over, and this is all with the highest quality audio and video.
In addition, VNUE concentrates on other entertainment experiences. These include comedy, plays, musicals, university lectures, professional demonstrations, and panel discussions, and also action sports and others.
On February 17, 2016, VNUE announced it was verified for trading on the OTCQB, the venture stage marketplace, effective as of February 17, 2016. Its shares continue to trade under the ticker symbol "VNUE." The OTC Markets Group, Inc. describes the OTCQB® as a Venture Marketplace for entrepreneurial and development stage U.S. and global companies.
VNUE announced that on February 18, 2016 it entered into an Equity Purchase Agreement with Tarpon Bay Partners LLC, an institutional investor. The Agreement establishes a new $10,000,000 credit financing mechanism. The proceeds will be used to fund acquisitions for VNUE, continued development of VNUE's platform, as well as for general working capital purposes.
VNUE, Inc. (VNUE), closed Friday's trading session at $0.0031, down 3.12%, on 270,000 volume with 5 trades. The average volume for the last 60 days is 184,608 and the stock's 52-week low/high is $0.0032/$0.075.
InMed Pharmaceuticals, Inc. (IMLFF)
SmallCapVoice reported earlier on InMed Pharmaceuticals, Inc. (IMLFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
InMed Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based therapies combined with unique drug delivery systems. A clinical stage biopharmaceutical enterprise, InMed is using its proprietary "Intelligent Cannabinoid Drug Design Platform" to identify new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. InMed Pharmaceuticals is headquartered in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.
At present, InMed is working on two products in its development pipeline. One is INM-750, for the treatment of Epidermolysis Bullosa. Epidermolysis Bullosa (EB) is a group of inherited connective tissue diseases. They share a common manifestation of extremely fragile skin, which blisters or tears from friction or trauma. The design of INM-750 is to include multiple cannabinoids as the active substance
The other is INM-085, for the treatment of Glaucoma. Glaucoma is a group of eye disorders that result in damage of the optic nerve. INM-085 will be the first ever glaucoma treatment developed, which has a multi-target, multi mechanism of action based therapy. The design of INM-085 is as a novel dual-action cannabinoid ocular therapy.
The Company’s discovery platform is a "network based platform" for identification on novel plant based therapies using complete algorithms to integrate data from many bioinformatics databases; a database on the structure of currently approved pharmaceutical products; and a wide-ranging database on more than 200,000 phytochemicals, including phytocannabinoids.
In November 2015, InMed Pharmaceuticals announced the appointment of Mr. Adam Cutler to its Board of Directors. Presently, Mr. Cutler is Senior Vice President of Corporate Affairs at Arbutus Biopharma. He was previously a Managing Director at The Trout Group LLC and Trout Capital LLC.
This past February, InMed Pharmaceuticals announced an update on its biosynthesis program. The aim of its biosynthesis program is to provide an alternate low cost and high quality process for producing phytocannabinoids for its product candidates. Normally, phytocannabinoids undergo extraction from the cannabis plant. The extraction process can be costly. In addition, it can result in unwanted by-products and impurities.
Utilizing metabolic engineering, the plant pathway for producing cannabinoids can be recreated in a microbial host and will be without the by-products and impurities seen with extraction. Furthermore, the process can be performed at industrial-scale, permitting low cost production of cannabinoids.
InMed Pharmaceuticals, Inc. (IMLFF), closed Friday's trading session at $0.1037, up 15.22%, on 19,600 volume with 6 trades. The average volume for the last 60 days is 42,883 and the stock's 52-week low/high is $0.0721/$0.30.
Mymetics Corp. (MYMX)
TopPennyStockMovers and The Dean reported previously on Mymetics Corp. (MYMX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mymetics Corp. is a biotechnology company based in Epalinges, Switzerland. It is developing next-generation preventative vaccines for infectious diseases. Its corporate vision is to become the market leader in the development of new generation mucosal and virosomes based vaccines. The Company has a Research Lab in the Netherlands. Mymetics’ shares trade on the OTC Markets’ OTCQB.
At present, the Company has five vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, Malaria, Herpes Simplex Virus, and the RSV vaccine. The design of Mymetics’ vaccines are to induce protection against early transmission and infection, centering on the mucosal immune response as a first-line defense that for some pathogens, may be vital for the development of an effective prophylactic vaccine.
Mymetics’ core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. The Company is concentrating on developing innovative preventative vaccines using two key scientific approaches. One is Virosomes as an effective adjuvant and a vaccine delivery method, and the other is unique antigen design by generating mucosal antibodies.
Through concentrating on these two scientific approaches, Mymetics’ strategy is addressing two critical needs in developing effective vaccines. One is the ability to build a first line of defense against viruses entering the blood stream through focusing on the mucosal layer. The other is the development of a new vaccine delivery platform, which does not use live attenuated or killed pathogens, while increasing the immunogenicity and stability of the vaccine. Mymetics' inventive approach is being validated via partnerships with top pharmaceutical or research organizations. These include PATH-MVI and the Bill and Melinda Gates Foundation.
This past January, Mymetics announced that its subsidiary, Bestewil Holding BV, received notice from RSV Corp.(RSVC) that it will no longer pursue the development of a vaccine technology for Respiratory Syncytial Virus (RSV) in order to concentrate on other infectious therapies. On December 27, 2013, Mymetics and RSVC, funded by Astellas Pharma, Inc., announced the signing of a License and Collaboration Agreement focusing on RSV that will now formally be terminated as of July 25, 2016.
Regarding the RSV virosome vaccine candidate, Mymetics will regain all the rights, results and data related to the research, development and commercialization once the license agreement with RSVC ends. Mymetics said that both parties will work together in the coming months to enable this transfer.
Mymetics Corp. (MYMX), closed Friday's trading session at $0.016, even for the day, on 70,121 volume with 4 trades. The average volume for the last 60 days is 35,947 and the stock's 52-week low/high is $0.0103/$0.03.
Epoxy, Inc. (EPXY)
TopPennyStockMovers reported previously on Epoxy, Inc. (EPXY), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Epoxy, Inc. is the developer of the Epoxy App, which is an application or "app" for iPhone iOS and Android operating systems. Epoxy is a unique smart phone application. The design of it is to conveniently connect business owners and consumers to reduce marketing frustrations. Epoxy is headquartered in Las Vegas, Nevada.
Epoxy is a fully integrated mobile application business. The commitment of Epoxy designers is to provide a superior and user-friendly product for business owners to reward loyal customers. The Epoxy mobile app gives loyal customers the ease of keeping track of rewards and punch cards all in one place. This is while also giving opportunities to review and share businesses with friends.
Epoxy provides businesses the ability to reward, share offers, and deliver information about special events with its customers, and offer card-less gift cards directly through smart phones. The Company has been targeting professional business services to add to its developing portfolio of clients. This includes Optometry, Health and Wellness, and also Technology firms.
Epoxy announced in April of 2015 that it successfully completed its Phase one expansion into Germany. It has started working on Phase two. Phase one consisted of rendering the best types of markets and deploying the Epoxy App in English. Phase Two consists of translating the Application to German and offering the German market incentives for signing up.
Epoxy has created an entirely different admin panel. The new admin panel design is cleaner and more intuitive. It provides business owners total control over the implementation of the Epoxy App. This control includes access to high-end analytics that report metrics. Business owners will also be able to easily update page content and send messages to the entire network, or single out and reward individual customers.
Last month, Epoxy announced that version 7.7.0 was approved by Apple and Android. This version has been rebuilt from the ground up, and it is a totally new system written in the latest languages.
Currently, Epoxy offers up to five different kinds of Rewards Cards. This enables businesses to further customize their customer's experience. Punch Cards, Membership Cards, Reverse Punch Cards and more now permit a totally customizable platform for businesses. Epoxy says that its Admin Panel is very capable. It allows businesses to see everything in real-time and stay connected to their customer base.
Epoxy, Inc. (EPXY), closed Friday's trading session at $0.0018, up 5.88%, on 431,000 volume with 2 trades. The average volume for the last 60 days is 1,939,784 and the stock's 52-week low/high is $0.0015/$0.08.
Halitron, Inc. (HAON)
The QualityStocks Daily Newsletter would like to spotlight Halitron, Inc. (HAON). Today, Halitron, Inc. closed trading at $0.0085, up 6.25%, on 388,000 volume with 11 trades. The stock’s average daily volume over the past 60 days is 336,193, and its 52-week low/high is $0.005/$0.05.
Halitron, Inc. today is excited to announce financial results for the year ending December 31st, 2015. Halitron Inc. generated $1,182,726 in gross sales at 73% gross profit. Sales, General & Administrative Expenses was $718,993 and Net Income/Loss was $146,025 or $.0006 Earnings Per Share. The Company also had $59,476 of expenses relating to the costs associated with being a public company.
Halitron, Inc. (HAON) is an equity holding company focused on the acquisition and efficient operation of sales, marketing and manufacturing businesses. The company primarily targets two types of acquisitions: bankrupt, distressed or insolvent businesses that can be inexpensively acquired and absorbed into Halitron's existing infrastructure; and profitable firms possessing a strategic operational fit that can benefit from Halitron's collective group of businesses. Following acquisition, businesses under Halitron's umbrella gain access to the company's established infrastructure, enabling the efficient and profitable manufacture and distribution of products.
Halitron's ongoing operations are structured into two strategic business units: a sales & marketing division and a manufacturing division. Through its sales & marketing division, the company owns operations in traditional marketing services and branded sales opportunities. Halitron's holdings through this division include NDG Holdings, Inc., a digital marketing services firm acquired in January 2015, and www.PiecesInPlaces.com, an online sales and marketing firm focused on office organization products acquired in February 2016. Through its manufacturing division, Halitron operates PRD Holdings, Inc., a Mexican manufacturing asset.
The company's management team is led by chief executive officer Bernard Findley. Over the past 20 years, Findley has amassed valuable experience promoting market growth in a variety of industries. During this time, he helped small- and mid-size businesses build up sales and seek out merger and acquisition opportunities. Over the past five years, Findley has rolled up and exited 16 bankrupt, insolvent or distressed brands, all of which continue to operate under new owners.
In February, Halitron set the stage for future growth when it entered into three separate letters of intent to make key profit generating acquisitions during the first quarter of 2016. When completed, these three acquisitions are expected to generate more than $1 million in annualized sales and establish the base of operations to lever future add-on acquisitions. "Over the past year we have positioned Halitron, Inc. to be a fast paced equity holding company, able to create significant shareholder wealth," Findley concluded in a news release. Disclaimer
Halitron, Inc. Company Blog
Halitron, Inc. News:
Halitron, Inc. Generates Over $1M in Sales
Halitron, Inc. Acquires ArchivalPhotoPages.com
Halitron, Inc. Finalizes Third Acquisition in 2016
Star Mountain Resources, Inc. (SMRS)
The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.94, up 34.29%, on 1,300 volume with 3 trades. The stock’s average daily volume over the past 60 days is 5,178, and its 52-week low/high is $0.35/$1.40.
Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.
Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.
The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.
Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer
Star Mountain Resources, Inc. Company Blog
Star Mountain Resources, Inc. News:
Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine
Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State
Star Mountain Resources, Inc. to Acquire Balmat Zinc Mine in New York State
Lingo Media Corp. (LMDCF)
The QualityStocks Daily Newsletter would like to spotlight Lingo Media Corp. (LMDCF). Today, Lingo Media Corp. closed trading at $0.6957, up 2.31%, on 9,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 4,536, and its 52-week low/high is $0.0862/$0.696.
Lingo Media Corp. (LMDCF) (LM.V) is an EdTech company that's changing the way the world learns English through an innovative combination of proven educational techniques and accessible technology. The company provides both online and print-based solutions through its two distinct business units: ELL Technologies and Lingo Learning. Through ELL Technologies, Lingo has made considerable progress in English-learning markets throughout Latin America. Through print-based publisher Lingo Learning, the company has built a significant presence in the Chinese education market, which includes more than 300 million students.
The company's groundbreaking English programs are developed and marketed for students at every stage of development – from the classroom to the boardroom. This versatility has allowed Lingo to secure contracts and build relationships with clients in a variety of markets around the globe. In Mexico, a subsidiary of the company has partnered with a recognized university that allows it to offer its courses along with certification. In Peru, the company's subsidiary provides its groundbreaking Scholar program to a branch of the country's armed forces.
Through ELL Technologies, Lingo also markets electronic learning solutions that are suitable for pre-readers. Lingo's Kids program – which features cross-platform, multi-browser compatibility – requires no prior knowledge of the English language, allowing the company to address the entire student life cycle in blended learning environments, traditional classroom settings and the home with one cutting-edge solution. The Kids program addresses the critically underserved pre-school market, which includes roughly 181.4 million children across Asia and 30.1 million throughout Latin America and the Caribbean, according to UNESCO.
Although Lingo has traditionally leaned on its print-based offerings as a primary source of revenue, the company's recent efforts to shift into the thriving eLearning market have highlighted the immense potential of a more heavily digital approach. In the second quarter of 2015, Lingo recorded more revenue from digital products than print-based solutions for the first time in its history. With the global eLearning market set to reach $107 billion in 2015, according to a report by Global Industry Analysts, the company's performance and growing foothold in some of the world's most rapidly expanding markets place it in a favorable position. Disclaimer
Lingo Media Corp. Company Blog
Lingo Media Corp. News:
Telefonica and Lingo Media Enter Into a Distribution Partnership for Peru
Lingo Media to Expand Latin America Sales Channel With Strategic Hire
Lingo Media's ELL Technologies to Launch "ELL Studio" App
Giggles N' Hugs, Inc. (GIGL)
The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.0709, up 1.29%, on 17,603 volume with 2 trades. The stock’s average daily volume over the past 60 days is 34,013, and its 52-week low/high is $0.0137/$0.2999.
Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.
In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.
Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.
Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.
Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer
Giggles N' Hugs, Inc. Company Blog
Giggles N' Hugs, Inc. News:
Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
Giggles Ní Hugs Signs Agreement with New York-Based Chardan Capital Markets
Giggles N Hugs to present at the 8th annual LD Micro Conference main event
Immune Therapeutics, Inc. (IMUN)
The QualityStocks Daily Newsletter would like to spotlight Immune Therapeutics, Inc. (IMUN). Today, Immune Therapeutics, Inc. closed trading at $0.1629, up 0.87%, on 116,158 volume with 30 trades. The stock’s average daily volume over the past 60 days is 208,382, and its 52-week low/high is $0.045/$0.36.
Immune Therapeutics, Inc. (IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect persons around the world. Building on the power of the body's natural immune system, the company's pipeline of products and immunotherapy technologies are designed to enhance treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.
Immune Therapeutics' most advanced clinical programs involve immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid growth factor) and its low dose naltrexone product (LDN), internationally known as Lodonal™, both of which have been shown to stimulate immune systems even in patients with advanced cancer.
Additionally, Immune Therapeutics is pursuing additional investigations for MENK and LDN as viable treatments for autoimmune conditions such as rheumatoid arthritis and multiple sclerosis; as an adjunct in cancer patients undergoing chemotherapy, radiation treatments or surgery; and as a complement to antibiotics in the treatment of a variety of infectious diseases, including patients with HIV/AIDS, in combination with retroviral drug therapy.
Immune Therapeutics and partners AHAR Pharma and GB Pharma Holdings recently completed a bridging trial to determine the safety and efficacy of LDN in patients with HIV, and have submitted data in connection with the filing of its New Drug Application for LDN with The National Agency for Food and Drug Administration and Control, (NAFDAC) of Nigeria. Disclaimer
Immune Therapeutics, Inc. Company Blog
Immune Therapeutics, Inc. News:
Immune Therapeutics, Inc. (IMUN) Using the Power of the Body to Fight Cancer and AIDS
Immune Therapeutics, Inc., Appoints Two New Board Members
Immune Therapeutics, Inc to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) to Introduce Details of New Platform Next Week
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs MOU to Acquire Revenue-Producing Company
- Dominovas Energy Corp. (DNRG) Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
- GTX Corp. (GTXO) Security Experts Discuss Threats and Solutions on SecuritySolutionsWatch.com
- Halitron, Inc. (HAON) Generates Over $1M in Sales
- Immune Therapeutics, Inc. (IMUN) Using the Power of the Body to Fight Cancer and AIDS
- International Stem Cell Corp. (ISCO) Announces 2015 Fourth Quarter and Year-End Results
- Lingo Media Corp. (LMDCF) Telefonica and Lingo Media Enter Into a Distribution Partnership for Peru
- Moxian, Inc. (MOXC) Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate
- Oakridge Global Energy Solutions, Inc. (OGES) Announces Start of Operations at New Manufacturing Facility
- OurPet's Company (OPCO) Reaches a Settlement With Competitor Over Durapet(R) Patents
- Star Mountain Resources Inc. (SMRS) Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine
- View Systems, Inc. (VSYM) to Acquire Y.M. Advantage, Inc.